Pictet North America Advisors’s iShares Biotechnology ETF IBB Stock Holding History

Pictet North America Advisors’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-2,530	Closed	-$273K	–	133
2020 Q1	$273K	Hold	2,530	–	–	0.05%	122
2019 Q4	$305K	Hold	2,530	–	–	0.04%	135
2019 Q3	$252K	Buy	2,530 +130	+5%	+$13.6K	0.03%	138
2019 Q2	$262K	Hold	2,400	–	–	0.04%	137
2019 Q1	$268K	Hold	2,400	–	–	0.04%	141
2018 Q4	$231K	Buy	+2,400	New	+$255K	0.02%	152

Other funds holding IBB

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Churchill Management Los Angeles, California $9.21B AUM 19.91% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

Pictet North America Advisors's IBB Position: Q2 2020 in Review

Pictet North America Advisors sold out of iShares Biotechnology ETF (IBB) in Q2 2020, closing a stake of 2,530 shares — an estimated $273K sold.

Pictet North America Advisors first reported a position in IBB in Q4 2018 and held it in 6 quarters. The position peaked at $305K in Q4 2019. 766 funds tracked by Wall St. Rank hold IBB as of Q2 2020.

Pictet North America Advisors reported no remaining iShares Biotechnology ETF position as of Q2 2020 after selling out during the quarter.
Pictet North America Advisors sold 2,530 iShares Biotechnology ETF shares in Q2 2020, an estimated $273K.
Pictet North America Advisors first reported a position in iShares Biotechnology ETF in Q4 2018 and held it in 6 quarters.
Pictet North America Advisors's iShares Biotechnology ETF position peaked at $305K in Q4 2019.
766 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2020.

Based on Pictet North America Advisors's 13F filing for Q2 2020, filed 13 Aug 2020.